Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?
875 Followers
BridgeBio Pharma (BBIO) Ownership Overview
49.67% Insiders
16.87% Mutual Funds
12.95% Other Institutional Investors
20.52% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail and individual investors. Approximately 29.82% of the company’s stock is owned by Institutional Investors, 49.67% is owned by Insiders and 20.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 13, 2024 | Hannah Valantine Director | Bought | $44476 |
| Jul 19, 2023 | Viking Global Investors Lp >10% Owner | Sold | $52500000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $116815 | |
| Mar 31, 2024 | Bought | $216440 | |
| Mar 31, 2024 | Bought | $1400645 | |
| Mar 31, 2024 | Bought | $5256400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,120,991 | Institution | 13.42% | 647,116,728 | |
| 13,031,939 | Institution | 6.96% | 335,702,749 | |
| 11,704,490 | Institution | 6.25% | 301,507,662 | |
| 6,500,970 | Institution | 3.47% | 167,464,987 | |
| 6,068,125 | Institution | 3.24% | 156,314,900 | |
| 2,941,336 | Institution | 1.57% | 75,768,815 | |
| 1,451,626 | Institution | 0.78% | 37,393,886 | |
| 1,412,033 | Institution | 0.75% | 36,373,970 | |
| 1,322,925 | Institution | 0.71% | 34,078,548 | |
| 1,310,481 | Institution | 0.70% | 33,757,991 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,704,490 | Institution | 6.25% | 301,507,662 | |
| 1,451,626 | Institution | 0.78% | 37,393,886 | |
| 1,322,925 | Institution | 0.71% | 34,078,548 | |
| 1,310,481 | Institution | 0.70% | 33,757,991 | |
| 1,297,669 | Institution | 0.69% | 33,427,953 | |
| 1,085,283 | Institution | 0.58% | 27,956,890 | |
| 946,496 | Institution | 0.51% | 24,381,737 | |
| 840,153 | Institution | 0.45% | 21,642,341 | |
| 728,118 | Institution | 0.39% | 18,756,320 | |
| 704,715 | Institution | 0.38% | 18,153,458 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,341,321 | Institution | 2.32% | 121,600,401 | |
| 3,530,132 | Institution | 1.89% | 98,878,997 | |
| 3,377,662 | Institution | 1.80% | 87,008,573 | |
| 2,767,455 | Institution | 1.48% | 69,186,375 | |
| 1,944,170 | Institution | 1.04% | 54,456,202 | |
| 1,179,431 | Institution | 0.63% | 33,035,862 | |
| 1,004,366 | Institution | 0.54% | 28,132,292 | |
| 1,035,943 | Institution | 0.55% | 26,685,892 | |
| 774,064 | Institution | 0.41% | 19,939,889 | |
| 649,843 | Institution | 0.35% | 16,246,075 |
FAQ
Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 12.95% of the company's stock is held by institutional investors, 49.67% is held by insiders, and 20.52% is held by retail investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.95% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.52% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
Andreas Halvorsen owns the most shares of BridgeBio Pharma Inc (BBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.